These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36248357)

  • 1. Bone Turnover in Relation to Thyroid-Stimulating Hormone in Hypothyroid Patients on Thyroid Hormone Substitution Therapy.
    Bjerkreim BA; Hammerstad SS; Eriksen EF
    J Thyroid Res; 2022; 2022():8950546. PubMed ID: 36248357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyrotropin versus thyroid hormone in regulating bone density and turnover in premenopausal women.
    Baqi L; Payer J; Killinger Z; Hruzikova P; Cierny D; Susienkova K; Langer P
    Endocr Regul; 2010 Apr; 44(2):57-63. PubMed ID: 20429634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do bone turnover markers reflect changes in bone microarchitecture during treatment of patients with thyroid dysfunction?
    Vinther CJ; Poulsen LH; Nicolaisen P; Obling ML; Brix TH; Hermann AP; Hegedüs L; Jørgensen NR; Hansen S; Bonnema SJ
    J Endocrinol Invest; 2023 Feb; 46(2):345-358. PubMed ID: 36064878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reference intervals for serum concentrations of three bone turnover markers for men and women.
    Michelsen J; Wallaschofski H; Friedrich N; Spielhagen C; Rettig R; Ittermann T; Nauck M; Hannemann A
    Bone; 2013 Dec; 57(2):399-404. PubMed ID: 24076251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reference intervals in Danish children and adolescents for bone turnover markers carboxy-terminal cross-linked telopeptide of type I collagen (β-CTX), pro-collagen type I N-terminal propeptide (PINP), osteocalcin (OC) and bone-specific alkaline phosphatase (bone ALP).
    Diemar SS; Lylloff L; Rønne MS; Møllehave LT; Heidemann M; Thuesen BH; Johannesen J; Schou AJ; Husby S; Wedderkopp N; Mølgaard C; Jørgensen NR
    Bone; 2021 May; 146():115879. PubMed ID: 33561588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reference intervals of biochemical bone turnover markers for Saudi Arabian women: a cross-sectional study.
    Ardawi MS; Maimani AA; Bahksh TA; Rouzi AA; Qari MH; Raddadi RM
    Bone; 2010 Oct; 47(4):804-14. PubMed ID: 20659600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The level of TSH appeared favourable in maintaining bone mineral density in postmenopausal women.
    Baqi L; Payer J; Killinger Z; Susienkova K; Jackuliak P; Cierny D; Langer P
    Endocr Regul; 2010 Jan; 44(1):9-15. PubMed ID: 20151763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical bone turnover markers in hormonal disorders in adults: a narrative review.
    Szulc P
    J Endocrinol Invest; 2020 Oct; 43(10):1409-1427. PubMed ID: 32335857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of levothyroxine therapy on bone mineral density and bone turnover markers in premenopausal women with thyroid cancer after thyroidectomy.
    Bin-Hong D; Fu-Man D; Yu L; Xu-Ping W; Bing-Feng B
    Endokrynol Pol; 2020; 71(1):15-20. PubMed ID: 31681976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone turnover markers in patients with differentiated thyroid carcinoma after levothyroxine withdrawal.
    Gao YC; Gu Q; Liu QP; Ge WL; Lu HK
    Clin Lab; 2010; 56(3-4):87-93. PubMed ID: 20476639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical markers of bone turnover as predictors of osteoporosis and osteoporotic fractures in men and women: 10-year follow-up of the Taiji cohort.
    Yoshimura N; Muraki S; Oka H; Kawaguchi H; Nakamura K; Akune T
    Mod Rheumatol; 2011 Dec; 21(6):608-20. PubMed ID: 21512822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reference intervals for bone turnover markers in Spanish premenopausal women.
    Guañabens N; Filella X; Monegal A; Gómez-Vaquero C; Bonet M; Buquet D; Casado E; Cerdá D; Erra A; Martinez S; Montalá N; Pitarch C; Kanterewicz E; Sala M; Surís X; Torres F;
    Clin Chem Lab Med; 2016 Feb; 54(2):293-303. PubMed ID: 26088062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cross-sectional study of bone turnover markers in healthy premenopausal women.
    de Papp AE; Bone HG; Caulfield MP; Kagan R; Buinewicz A; Chen E; Rosenberg E; Reitz RE
    Bone; 2007 May; 40(5):1222-30. PubMed ID: 17331821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of carboxyterminal cross-linked telopeptide of type I collagen (ICTP) in the differential diagnosis of the syndromes of inappropriate secretion of TSH.
    Persani L; Preziati D; Matthews CH; Sartorio A; Chatterjee VK; Beck-Peccoz P
    Clin Endocrinol (Oxf); 1997 Aug; 47(2):207-14. PubMed ID: 9302396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subclinical thyroid dysfunction and circulating thyroid hormones are not associated with bone turnover markers or incident hip fracture in older men.
    Siru R; Alfonso H; Chubb SAP; Golledge J; Flicker L; Yeap BB
    Clin Endocrinol (Oxf); 2018 Jul; 89(1):93-99. PubMed ID: 29655173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction in PINP, a marker of bone metabolism, with raloxifene treatment and its relationship with vertebral fracture risk.
    Reginster JY; Sarkar S; Zegels B; Henrotin Y; Bruyere O; Agnusdei D; Collette J
    Bone; 2004 Feb; 34(2):344-51. PubMed ID: 14962813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline bone turnover marker levels can predict change in bone mineral density during antiresorptive treatment in osteoporotic patients: the Copenhagen bone turnover marker study.
    Bønløkke SE; Rand MS; Haddock B; Arup S; Smith CD; Jensen JEB; Schwarz P; Hovind P; Oturai PS; Jensen LT; Møller S; Eiken P; Rubin KH; Hitz MF; Abrahamsen B; Jørgensen NR
    Osteoporos Int; 2022 Oct; 33(10):2155-2164. PubMed ID: 35729342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thalassemic osteopathy: a new marker of bone deposition.
    Baldini M; Forti S; Orsatti A; Marcon A; Ulivieri FM; Airaghi L; Zanaboni L; Cappellini MD
    Blood Cells Mol Dis; 2014; 52(2-3):91-4. PubMed ID: 24091145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of bone turnover markers in peripheral blood and bone marrow aspirate.
    Ornstrup MJ; Kjær TN; Harsløf T; Jørgensen NR; Pedersen SB; Langdahl BL
    Bone; 2018 Nov; 116():315-320. PubMed ID: 30176391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of denosumab on bone turnover markers in postmenopausal osteoporosis.
    Eastell R; Christiansen C; Grauer A; Kutilek S; Libanati C; McClung MR; Reid IR; Resch H; Siris E; Uebelhart D; Wang A; Weryha G; Cummings SR
    J Bone Miner Res; 2011 Mar; 26(3):530-7. PubMed ID: 20839290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.